oasis 2 semaglutide 🚨 Oral 25 mg delivers double-digit weight loss in OASIS-4 (Phase 3 trial) - Dose-equivalence reference based on pivotal

The turnabout for each came after both insurers ended automatic coverage of the blockbuster GLP-1 weight loss drugs such as Wegovy and Zepbound solely for the treatment of obesity

Semaglutide is a simpler molecule targeting only the GLP-1 receptor, making microdosing more straightforward

Semaglutide works by mimicking a natural hormone (GLP-1) that helps regulate blood sugar, slow digestion, and reduce appetite

The better news is that for many, the reactions eventually fade or disappear altogether

Enhanced Pharma vials ship factory-sealed and ready for storage

Dosing begins at a low level and is gradually increased as tolerated to maximize benefits and minimize side effects